Seeger John D, Kurth Tobias, Walker Alexander M
Ingenix i3 Drug Safety, Waltham, Massachusetts, USA.
Med Care. 2007 Oct;45(10 Supl 2):S143-8. doi: 10.1097/MLR.0b013e318074ce79.
In observational research, propensity score techniques can be used to account for baseline differences between compared therapies. Although propensity scores are used increasingly often, their limitations in settings without complete data may not be recognized.
We sought to evaluate the ability of propensity score matching to mitigate confounding by indication in an observational study of the effect of statin therapy on acute myocardial infarction (AMI). Matching was performed at random, and with propensity scores that incorporated a reduced or expanded set of variables. RESEARCH DESIGN/SUBJECTS: This was a propensity score matched cohort study using members of a health insurer database.
Exposure to statin therapy was assessed at the beginning of follow-up with all cohort members being statin initiators or noninitiators, and the outcome of AMI was identified on the basis of claims codes.
Matching on the basis of the propensity score provided results that are similar in magnitude to randomized clinical trials, suggesting that confounding was mitigated. However, matching on a propensity score created on a reduced set of variables yielded a result that suggested no effect of statin therapy, and demonstrated substantial imbalance on some variables that were not part of the propensity score.
Propensity score matching can balance with respect to variables not explicitly included in the score, but external data are required to evaluate this.
在观察性研究中,倾向评分技术可用于解释比较疗法之间的基线差异。尽管倾向评分的使用越来越频繁,但在没有完整数据的情况下其局限性可能未被认识到。
我们试图在一项关于他汀类药物治疗对急性心肌梗死(AMI)影响的观察性研究中,评估倾向评分匹配减轻适应证混杂的能力。匹配是随机进行的,并使用纳入了减少或扩展变量集的倾向评分。研究设计/研究对象:这是一项使用健康保险公司数据库成员的倾向评分匹配队列研究。
在随访开始时评估他汀类药物治疗的暴露情况,所有队列成员均为他汀类药物起始使用者或非使用者,并根据理赔代码确定AMI的结局。
基于倾向评分进行匹配得到的结果在量级上与随机临床试验相似,表明混杂得到了减轻。然而,基于减少变量集创建的倾向评分进行匹配得到的结果表明他汀类药物治疗无效果,并在一些不属于倾向评分的变量上显示出明显的不平衡。
倾向评分匹配可以在未明确纳入评分的变量方面实现平衡,但需要外部数据来评估这一点。